Related Experiment Video
Updated: May 10, 2026

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
Published on: August 18, 2020
Chewing Beedis: A Case of Cross-Tobacco use in a Patient with Schizophrenia
Govindappa Lakshmana1, Narayana Manjunatha, Ramasamy Dhanasekara Pandian
1Department of Social Work, School of Social and Behavioral Sciences, Central University of Karnataka, Gulbarga, Bangalore, Karnataka, India.
Abstract:
While tobacco use occurs in many forms all over the world, there is little information on cross-tobacco use. Authors report an unusual case of tobacco use in the form of chewing beedies which are normally smoked (cross-tobacco use). A 22-year-old single female, diagnosed with schizophrenia for the last 6 years, started chewing beedies from the age of 15 years and was using it in a dependent pattern since 7 years. After 3 years of treatment for her schizophrenia, patient's family pressured her to seek tobacco cessation treatment. Initial treatment with nicotine gum replacement and behavioral counseling did not prove useful. Subsequently she was treated with bupropion 300 mg/day and able to successfully abstain. Cross-tobacco use is relatively rare, and merits further study, especially in the mentally ill population.
Related Concept Videos
CNS Depressants: Alcohol and Nicotine
Drug Dependence
Stress Prevention and Stress Management Techniques IV
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Psychosis: Goals of Pharmacotherapy
